comparemela.com

Latest Breaking News On - Eversana - Page 5 : comparemela.com

Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023

CAMBRIDGE, Mass., Feb. 21, 2023 Mersana Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates targeting. | February 21, 2023

United kingdomJason fredetteMersana therapeutics incGlobenewswire incMersana therapeuticsNc stock exchangePress releaseOnjugates mrsn us59045l1061

EVERSANA CONSULTING Named a Best Boutique Consulting Firm by Vault For the Second Consecutive Year

/PRNewswire/ EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm.

United statesJim langMatt braunBoutique consulting firmFirsthand findings

Merck KGaA, Darmstadt, Germany Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Not intended for UK-based media Collaboration complements Merck KGaA, Darmstadt, Germany's internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist

United statesUnited kingdomPaul lyneAnna protopapasHead of research unit oncologyMerck kgaMerck kgaaMersana therapeutics incUnited kingdom basedMersana therapeuticsResearch unit oncologyChief executive officer

Versana Launches Digital Data Platform, Delivering the Modern Foundation to Transform the $5T Syndicated Loan Market

/PRNewswire/ Versana today announced the launch of its industry-backed syndicated loan platform, bringing to market a new centralized solution that.

United statesAlex naboicheckMichael kingsleyJoseph ferraioloJeff cohenCynthia sachsDavid kampPrnewswire versanaNina guinchardForefront communications for versanaUs leveraged loan trading at bankCredit suisseVersana foundingBoard member cynthiaLoan tradingDebt capital markets operations

EVERSANA® Names Experienced Life Sciences Leader Sy Pretorius Chief Operating Officer & President, Outsourced Solutions to Propel Next-Generation Commercialization Services Worldwide

/PRNewswire/ EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today named Sy Pretorius as the company s new.

United statesUnited kingdomJim langMatt braunSy pretoriusPatient servicesCompliance servicesHarvard medical schoolDrug developmentCorporate communicationsInformation technologyField deployment solutionsBusiness administrationClinical developmentChief operating officerChief medical officer

vimarsana © 2020. All Rights Reserved.